Clinical studies with systemic administration of antimetabolites of pyrimidine nucleosides in viral infections.
D000310:Adrenal Gland Neoplasms / Q000150:complications; D000328:Adult; D000368:Aged; D000963:Antimetabolites / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D005467:Floxuridine / Q000627:therapeutic use*; D005734:Gangrene / Q000209:etiology; D006562:Herpes Zoster / Q000150:complications*; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use*; D007223:Infant; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D012208:Rhabdomyosarcoma / Q000150:complications; D012899:Smallpox / Q000150:complications*; D014611:Vaccination; D014615:Vaccinia / Q000150:complications; D014777:Virus Diseases / Q000150:complications* / Q000188:drug therapy*
D000963:Antimetabolites; D005467:Floxuridine; D003561:Cytarabine; D007065:Idoxuridine